Weiboxin Shines at the 6th International Veterinary Testing and Diagnostics Conference! A Live Look at the Bustling T211 Booth

From June 14 to 16, the Sixth International Veterinary Diagnostic Conference (AVDC) and the Asia Veterinary Instruments and Pharmaceuticals Exhibition were grandly held at the Nanjing International Exhibition Center. This edition of the conference brought together leading figures from the global veterinary diagnostics industry. Leveraging its status as a premier international forum, the event facilitated in-depth discussions on cutting-edge technologies and innovative concepts, while fostering the exchange and integration of research findings with practical experience. These efforts have provided significant momentum for advancing the industry ecosystem to a higher level and for building a healthy, efficient veterinary diagnostics system.

At this industry extravaganza, Guangzhou Weiboxin Biotechnology Co., Ltd. (hereinafter referred to as “Weiboxin Bio”) With Innovative Product (One-Step RT-PCR Master Mix) with Technical Strength Becoming the center of attention, the booth was bustling with visitors, and the atmosphere of exchange was exceptionally vibrant, perfectly embodying “ Professional testing for animal epidemics; technology-driven healthy farming. Guided by this business philosophy, Weiboxin Biotechnology successfully concluded its participation in the exhibition.

On the opening day, Weiboxin Biotech’s exhibit booth, with its striking brand identity and professional display design, drew a large crowd of industry professionals. The event enjoyed an unprecedented level of attendance and showcased three major highlights:

1. A bustling consultation area 
A long queue consistently formed at the booth’s information desk, as professionals from large-scale livestock farms, animal disease control centers, and university research institutes eagerly sought to learn about Weiboxin Bio’s latest R&D solutions for animal disease detection. The company’s entire sales team was on hand to provide detailed explanations to attendees. Test kits for African swine fever, porcine reproductive and respiratory syndrome, classical swine fever, porcine circovirus, and other diseases technical advantages.

2. Live Demonstration Elicits Awe

Technical personnel demonstrated the nucleic acid extraction process using a fully automated nucleic acid extractor, with the entire procedure able to be completed in as little as 15 minutes. This highlight has also drawn widespread attention from numerous leaders, veterinarians, and laboratory testing personnel.

3. Cutting-Edge Product Portfolio Captures Attention

The core area of the booth showcases Weiboxin Bio’s independently developed Molecular diagnostic products and Immunology products , including:

Fluorescent PCR detection kit for African swine fever virus (Veterinary Drug Registration No. 191438923), ELISA antibody detection kit for porcine reproductive and respiratory syndrome virus (Veterinary Drug Registration No. 191438213), ELISA blocking assay antibody detection kit for classical swine fever virus (Veterinary Drug Registration No. 191438875), and ELISA antibody detection kit for porcine circovirus type 2 (Veterinary Drug Registration No. 191438851).

Owing to their precision, efficiency, and reliability, these products have become the preferred tools for disease prevention and control in animal husbandry as well as for laboratory diagnostics.

Weiboxin Bio also offered at this exhibition Free testing   Services: Subtype identification of blue ear disease and detection of diarrhea symptoms.

Classification and Identification of Blue Ear Disease

Test sample: Lung, tonsil, oral swab, brain tissue, whole blood, etc.

Please provide suspected positive samples, and we will conduct free identification to determine whether they are highly pathogenic strains, NADC30 strains, classical strains, or European strains.

Detection of Diarrheal Symptoms

Test sample: Intestinal contents, mesenteric lymph nodes, excreta, etc.

Please provide a suspected sample for diarrhea, and we will perform free testing for Porcine Epidemic Diarrhea Virus (PEDV), Transmissible Gastroenteritis Virus (TGEV), Porcine Delta Coronavirus (PDCoV), and Porcine Group A Rotavirus (PRV-A).

Weiboxin Biotechnology will steadfastly uphold the philosophy of “Pursuing Excellence, Innovating Brands,” continuously advancing the innovative application of molecular diagnostic technologies in veterinary medicine to build a robust technological defense for safeguarding animal health and ensuring food safety.

Weiboxin Biotechnology—Empowering Every Life with Precise Diagnostics!

For animal disease testing reagents, please choose the Weiboxin brand.

Be aware of Weiboxin Bio All products of!

Official consultation phone numbers: 020-66377266 / 135 3988 6748, Ms. Dai

Guangzhou Weiboxin Biotechnology Co., Ltd. is located in the national-level innovation park—Guangzhou Science City. The company is a provincial-level “Little Giant” high-tech enterprise specializing in the forward R&D, manufacturing, sales, and technical services of diagnostic reagents for animal epidemics. It has been recognized as a “Contract-Honoring and Credit-Keeping Enterprise” by Guangdong Province and as a provincial demonstration unit for intellectual property. Additionally, it serves as an industry–university–research base for Guangdong Food and Drug Vocational College and as an executive director unit of the Veterinary Diagnostic and Biological Products Committee of the Guangdong Society of Animal Husbandry and Veterinary Medicine. The company has been designated as an innovative, high-potential enterprise by multiple research institutes, including the Entrepreneurship College of Jinan University in Guangdong Province, and has been awarded the titles of “Specialized, Refined, Distinctive, and Innovative” enterprise at both municipal and provincial levels. It has also received the “Most Investment-Valuable Enterprise” award and the annual title of “ASF and Swine Disease Testing Service Provider.” Furthermore, it holds veterinary drug product approval numbers issued by the Ministry of Agriculture and Rural Affairs: Veterinary Drug Registration No. 191438923 (Fluorescent PCR Test Kit for African Swine Fever Virus), Veterinary Drug Registration No. 191438213 (ELISA Antibody Test Kit for Porcine Reproductive and Respiratory Syndrome Virus), Veterinary Drug Registration No. 191438875 (Blocking ELISA Antibody Test Kit for Classical Swine Fever Virus), and Veterinary Drug Registration No. 191438851 (ELISA Antibody Test Kit for Porcine Circovirus Type 2). The company was awarded the Excellence Prize in the Growth Category of the Biopharmaceutical Industry at the 11th China Innovation and Entrepreneurship Competition, the Provincial Second Prize in the Growth Category of the Nanotechnology Industry Technology Competition at the Science and Technology Innovation and Entrepreneurship Contest, and the National Third Prize in the Growth Category of the National Finals of the Nanotechnology Industry Technology Innovation Special Competition at the China Innovation and Entrepreneurship Competition. It has consecutively received the A-Level Tax Credit Honor Certificate, the Four-Star Trademark Brand Certification, and the Two-Integration Management System Assessment Certificate each year. In addition, it has obtained ISO 9001 International Quality Management System Certification, ISO 14001 International Environmental Management System Certification, and GMP certification from the Ministry of Agriculture. Since its establishment, the company has been granted a total of 24 patents, including 5 invention patents, 15 utility model patents, and 4 design patents, as well as more than ten trademarks.

The company boasts robust technical capabilities and a team of world-class professionals, including dozens of masters, doctors, and returnees who studied abroad, as well as numerous senior-title technical experts. Currently, the company’s primary focus is on the research and development of molecular diagnostic reagents. Its core R&D team has developed more than 600 products spanning molecular diagnostics and immunoassays, including public-health–oriented fluorescent PCR test kits, animal disease–control–oriented fluorescent PCR test kits, clinical and research–grade fluorescent quantitative PCR kits, and transgenic–identification test kits (ZL2006). The company has also established a nationwide distribution network covering over ten major cities, such as Beijing, Shanghai, Hangzhou, Nanjing, Xi’an, Chongqing, Lanzhou, Zhengzhou, and Qingdao.

Looking ahead, Weiboxin will remain steadfast in its commitment to continuously enhance product quality and service standards. Leveraging a rapid and efficient research platform and abundant biomedical resources, we will conduct extensive and in-depth R&D and scientific research in the biomedical field, thereby contributing to human health and advancing life sciences. Quality is our lifeline; innovation is our soul. Upholding this guiding principle, we will strive to become the premier supplier of rapid diagnostic reagents and instruments.